BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6691897)

  • 1. Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.
    Uchida A; Colot M; Micksche M
    Br J Cancer; 1984 Jan; 49(1):17-23. PubMed ID: 6691897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A; Micksche M; Hoshino T
    Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
    Timonen T; Ortaldo JR; Herberman RB
    J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression by human placental protein 14 of natural killer cell activity.
    Okamoto N; Uchida A; Takakura K; Kariya Y; Kanzaki H; Riittinen L; Koistinen R; Seppälä M; Mori T
    Am J Reprod Immunol; 1991 Dec; 26(4):137-42. PubMed ID: 1840727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells in carcinomatous and tuberculous pleurisy. Phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions.
    Okubo Y; Nakata M; Kuroiwa Y; Wada S; Kusama S
    Chest; 1987 Sep; 92(3):500-4. PubMed ID: 3622027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.